Peer-reviewed journal articles (26)
  1. 13. Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., De Decker, R., Buée, L., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo. The American journal of pathology, 186(10), 2709-2722. doi:10.1016/j.ajpath.2016.06.008
  2. 14. Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara Panos, C., Belkouch, M., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2016). Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiology of disease, 94, 32-43. doi:10.1016/j.nbd.2016.05.017
  3. 15. Gilissen, E., Leroy, K., Yilmaz, Z., Kövari, E., Bouras, C., Boom, A., Poncelet, L., Erwin, J. J., Sherwood, C. C., Hof, P., & Brion, J. P. (2016). A neuronal aging pattern unique to humans and common chimpanzees. Brain Structure and Function (Print Edition), 221(1), 647-664. doi:10.1007/s00429-014-0931-5
  4. 16. Audouard, E., Van Hees, L., Suain, V., Yilmaz, Z., Poncelet, L., Leroy, K., & Brion, J. P. (2015). Motor Deficit in a Tauopathy Model Is Induced by Disturbances of Axonal Transport Leading to Dying-Back Degeneration and Denervation of Neuromuscular Junctions. The American journal of pathology, 185(10), 2685-2697. doi:10.1016/j.ajpath.2015.06.011
  5. 17. Ando, K., Kabova, A., Stygelbout, V., Leroy, K., Heraud, C., Frédérick, C., Suain, V., Yilmaz, Z., Authelet, M., Dedecker, R., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2014). Vaccination with Sarkosyl Insoluble PHF-Tau Decrease Neurofibrillary Tangles Formation in Aged Tau Transgenic Mouse Model: A Pilot Study. Journal of Alzheimer's disease, 40(0), S135-S145. doi:10.3233/JAD-132237
  6. 18. Heraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J. N., & Brion, J. P. (2013). Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiology of disease, 62C, 100-112. doi:10.1016/j.nbd.2013.09.010
  7. 19. Leroy, K., Ando, K., Laporte, V., Dedecker, R., Suain, V., Authelet, M., Heraud, C., Pierrot, N., Yilmaz, Z., Octave, J. N., & Brion, J. P. (2012). Lack of Tau Proteins Rescues Neuronal Cell Death and Decreases Amyloidogenic Processing of APP in APP/PS1 Mice. The American journal of pathology, 181(6), 1928-1940. doi:10.1016/j.ajpath.2012.08.012
  8. 20. Ando, K., Leroy, K., Heraud, C., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2011). Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. The American journal of pathology, 178(2), 803-816. doi:10.1016/j.ajpath.2010.10.034
  9. 21. Ando, K., Leroy, K., Heraud, C., Kabova, A., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2010). Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochemical Society transactions, 38(4), 1001-1005. doi:10.1042/BST0381001
  10. 22. Leroy, K., Ando, K., Heraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J. P. (2010). Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. Journal of Alzheimer's disease, 19(2), 705-719. doi:10.3233/JAD-2010-1276
  11. 23. Leroy, K., De Decker, R., Suain, V., Authelet, M., Yilmaz, Z., & Brion, J. P. (2009). C9 Tau et toxicité de l’amyloïde Aß dans les modèles transgéniques APP. Revue neurologique, 165(10), 23. doi:10.1016/S0035-3787(09)72562-7
  12. 24. Killick, R., Scales, G., Leroy, K., Causevic, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al-Qassab, H., Stephenson, J., Yilmaz, Z., Giese, K. P., Brion, J. P., Withers, D. J., & Lovestone, S. (2009). Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochemical and biophysical research communications, 386(1), 257-262. doi:10.1016/j.bbrc.2009.06.032
    13. << Previous 1 2 3 4 5 6 7 Next >>